论文部分内容阅读
目的:回顾性分析我院热毒宁注射液的临床应用及不良反应发生情况。方法:选择我院收治的527例使用热毒宁注射液治疗患者作为本文研究对象,统计分析热毒宁注射液的临床应用疗程、用药频率、剂量分布及冲管情况,同时观察热毒宁注射液治疗各类疾病的临床疗效及不良反应发生率。结果:527例患者年龄在5-10岁之间者比例高达63.9%(337/527),用药剂量中以10-15ml为主,用药疗程以5-7d为主。我院应用热毒宁注射液主要治疗肺炎、上呼吸道感染及流感,用药患者比例明显高于其他疾病患者(P<0.05)。527例用药患者中出现腹泻、恶心呕吐等不良反应共计24例,不良反应发生率为4.6%(24/527)。结论:热毒宁注射液治疗呼吸系统疾病的疗效确切,但临床也存在不合理应用情况,加强热毒宁注射液临床应用监控,可有效提高其应用安全性。
Objective: To retrospectively analyze the clinical application and adverse reactions of Renduining injection in our hospital. Methods: 527 cases treated with Renduining injection in our hospital were selected as the object of this study. The clinical application course, frequency of drug use, dose distribution and the situation of red-tube injection were statistically analyzed. At the same time, Liquid treatment of various diseases, the clinical efficacy and incidence of adverse reactions. Results: The proportion of 527 patients aged 5-10 years old was as high as 63.9% (337/527). The dosage was mainly 10-15ml. The medication was mainly 5-7 days. Our hospital application of heat drug rather injection for the treatment of pneumonia, upper respiratory tract infection and influenza, the proportion of patients was significantly higher than other diseases (P <0.05). A total of 247 cases of adverse reactions such as diarrhea, nausea and vomiting occurred in 527 patients, with a rate of adverse reactions of 4.6% (24/527). Conclusion: The effect of Revedunin Injection in the treatment of respiratory diseases is exact, but there are also unreasonable clinical applications. The clinical application of Reverining Injection can be strengthened to improve the safety of its application.